This is an alphabetical list of the abbreviations and acronyms used across LOINC. It is a work in progress and, to date, primarily contains abbreviations/acronyms used in various LOINC Parts, except for Components.
The list does not include combinations of abbreviations and acronyms that are separated by a delimiter (e.g. Ser/Plas, Ser+CSF) since we have many such combinations in LOINC. To learn more about the use and meaning of delimiters in various parts of a LOINC term, please refer to Section 2 of the LOINC Users’ Guide.
This list also does not include abbreviations used in the Class field. You can find exhaustive lists of Class values by Class Type in Appendix B of the Users’ Guide.
If you have a specific abbreviation or acronym that you were looking for that is not in this list, please contact us.
| Abbreviation/Acronym | Meaning | Areas of LOINC |
|---|---|---|
| 1.5H | 1.5 hours | Timing; Challenge timing |
| 100D | 100 days | Timing |
| 10D | 10 days | Timing; Challenge timing |
| 10H | 10 hours | Timing |
| 10M | 10 minutes | Timing; Challenge timing |
| 10Y | 10 years | Timing |
| 12H | 12 hours | Timing; Challenge timing |
| 12Mo | 12 months | Timing |
| 14D | 14 days | Timing |
| 15M | 15 minutes | Timing; Challenge timing |
| 180D | 180 days | Timing |
| 18H | 18 hours | Timing |
| 1D | 1 day | Timing |
| 1H | 1 hour | Timing; Challenge timing |
| 1M | 1 minute | Timing; Challenge timing |
| 1Mo | 1 month | Timing; Challenge timing |
| 1W | 1 week | Timing; Challenge timing |
| 1Y | 1 year | Timing |
| 2.5H | 2.5 hours | Timing; Challenge timing |
| 20M | 20 minutes | Timing; Challenge timing |
| 24H | 24 hours | Timing; Challenge timing |
| 25M | 25 minutes | Timing; Challenge timing |
| 2D | 2 days | Timing; Challenge timing |
| 2H | 2 hours | Timing; Challenge timing |
| 2M | 2 minutes | Timing; Challenge timing |
| 2Mo | 2 months | Timing; Challenge timing |
| 2W | 2 weeks | Timing; Challenge timing |
| 2Y | 2 years | Timing |
| 30D | 30 days | Timing |
| 30M | 30 minutes | Timing; Challenge timing |
| 3D | 3 days | Timing; Challenge timing |
| 3H | 3 hours | Timing; Challenge timing |
| 3-HPMA | 3-Hydroxypropyl Mercapturic acid | Component |
| 3M | 3 minutes | Timing; Challenge timing |
| 3Mo | 3 months | Timing; Challenge timing |
| 3W | 3 weeks | Timing; Challenge timing |
| 3Y | 3 years | Timing |
| 45M | 45 minutes | Timing |
| 48H | 48 hours | Timing |
| 4D | 4 days | Timing; Challenge timing |
| 4H | 4 hours | Timing; Challenge timing |
| 4M | 4 minutes | Timing; Challenge timing |
| 4W | 4 weeks | Timing; Challenge timing |
| 5D | 5 days | Timing; Challenge timing |
| 5H | 5 hours | Timing; Challenge timing |
| 5M | 5 minutes | Timing; Challenge timing |
| 6D | 6 days | Timing; Challenge timing |
| 6H | 6 hours | Timing; Challenge timing |
| 6M | 6 minutes | Timing; Challenge timing |
| 6Mo | 6 months | Timing |
| 72H | 72 hours | Timing |
| 7D | 7 days | Timing; Challenge timing |
| 7H | 7 hours | Timing; Challenge timing |
| 7M | 7 minutes | Timing; Challenge timing |
| 8H | 8 hours | Timing; Challenge timing |
| 8M | 8 minutes | Timing; Challenge timing |
| 90D | 90 days | Timing |
| 90M | 90 minutes | Timing |
| 9H | 9 hours | Timing |
| 9M | 9 minutes | Timing; Challenge timing |
| Ab | Antibody | Component |
| AC | Abdominal circumference | Method |
| Accel | Acceleration | Property |
| ACnc | Arbitrary concentration | Property |
| ACnt | Arbitrary content | Property |
| Addr | Address | Property |
| ADL | Activities of daily living | Component |
| AFr | Arbitrary fraction | Property |
| Ag | Antigen | Component |
| Aggl | Agglutination | Method |
| Amnio fld | Amniotic fluid | System |
| Anat | Anatomy | Property |
| Angio | Angiography | Method |
| AP | Apply Externally | Challenge route |
| Aper | Appearance | Property |
| ArArea | Area/Area | Property |
| ARat | Arbitrary Rate | Property |
| Arb | Arbitrary | Property |
| AreaFr | Area Fraction | Property |
| AreaRto | Area Ratio | Property |
| ArEnrg | Energy/Area | Property |
| ArLen | Length/Area | Property |
| ArMass | Mass/Area | Property |
| ArResis | Resistance/Area | Property |
| ArVol | Volume/Area | Property |
| ArVRat | Volume Rate/Area | Property |
| ASHA NOMS | ASHA National Outcomes Measurement System | Method |
| Asp | Aspirate | System |
| AUC | Area under the curve | Property |
| B | Buccal | Challenge route |
| Bib | Bibliographic Citation | Property |
| Bil fld | Bile fluid | System |
| Bld | Whole blood | System |
| Bld.dot | Dried blood spot | System |
| BldA | Blood arterial | System |
| BldC | Blood capillary | System |
| BldCo | Blood – cord | System |
| BldL | Blood bag | System |
| BldMV | Blood- mixed Venous | System |
| BldP | Blood – peripheral | System |
| BldV | Blood venous | System |
| Blood group antibody screen | Blood group antibody screen | Method |
| Body fld | Body fluid, unsp | System |
| Bone mar | Marrow (bone) | System |
| BS | Bishop Score Assessment | Method |
| CAct | Catalytic Activity | Property |
| CAS | Coronavirus Anxiety Scale | Method |
| CBA IFA | Cell binding immunofluorescent assay | Method |
| CBS-8 | Columbia Behavior Scale for Dementia | Method |
| CCnc | Catalytic Concentration | Property |
| CCnt | Catalytic Content | Property |
| CDC | Complement-dependent cytotoxicity | RelatedName |
| CDC | U.S. Centers for Disease Control and Prevention | Component; Method |
| CFst | Calorie fast | Challenge |
| CFr | Catalytic Fraction | Property |
| CFr.DF | Decimal Catalytic Fraction | Property |
| Chromo | Chromogenic/Enzymatic Assay | Method |
| Circ | Circumference | Property |
| CircFr | Circumference Fraction | Property |
| CKD-EPI | Creatinine and Cystatin C-based formula | Method |
| ClockTime | Clock Time | Property |
| Cmplx | Complex | Property |
| Cnjt | Conjunctiva | System |
| Cnl | Cannula | System |
| CNPI | Checklist of nonverbal pain indicators | Method |
| Coag | Coagulation Assay | Method (also Class) |
| Col | Colostrum | System |
| ColorRto | Color Ratio | Property |
| COMI | Core Outcome Measures Index | Method |
| Comp fix | Complement Fixation | Method |
| Compli | Compliance | Property |
| CompliRto | Compliance Ratio | Property |
| COPE | COvid-19 Participant Experience (COPE) | Method |
| COVEX | COVID-19 Experiences | Method |
| CRat | Catalytic Rate | Property |
| CRBS | Coronavirus Racial Bias Scale | Method |
| Crn | Cornea | System |
| CRto | Catalytic Ratio | Property |
| CSF | Cerebral spinal fluid | System |
| CSub | Catalytic Substance | Property |
| CT | Computed tomography | Method |
| CTp | Catheter tip | System |
| Cvm | Cervical mucus | System |
| Cvx | Cervix | System |
| Cyto stain | Cytology Stain | Method |
| Desc | Description | Property |
| Dial fld | Dialysis fluid | System |
| Dial fld prt | Peritoneal dialysis fluid | System |
| Diam | Diameter | Property |
| DNA | deoxyribonucleic acid | Component |
| Doc | Document | Scale |
| DT | Dental | Challenge route |
| DtTmRange | Date and Time Range | Property |
| Duod fld | Duodenal fluid | System |
| Dur | Duration | Timing |
| Dx | Diagnosis | Component |
| EEG | Electroencephalogram | System; Method |
| Elcur | Electrical current | Property |
| ElecCon | Electrical Conductivity | Property |
| Elpot | Electrical Potential (Voltage) | Property |
| ElpotRat | Voltage Rate (=Amperage) | Property |
| ElpotRto | Electrical Potential Ratio | Property |
| EmailAddr | E-mail Address | Property |
| Enctr | Duration of an encounter (hospital stay, visit). | Timing |
| Endomet | Endometrium | System |
| EngCnc | Energy Concentration | Property |
| EngCnt | Energy Content | Property |
| EngDiff | Energy Difference | Property |
| EngFr | Energy Fraction | Property |
| EngRat | Power = Energy/Time | Property |
| EngRatFr | Energy Rate Fraction | Property |
| EngRto | Energy Ratio | Property |
| Enrg | Energy | Property |
| EntCat | Entitic Catalytic Activity | Property |
| EntLen | Entitic Length | Property |
| EntLogNum | Logarithmic Entitic Number | Property |
| EntMass | Entitic Mass | Property |
| EntNum | Entitic Number | Property |
| EntSRto | Entitic Substance Ratio | Property |
| EntSub | Entitic Substance | Property |
| EntVol | Entitic Volume | Property |
| EP | Epidural | Challenge route |
| Equ | Equation | Property |
| ET | Endotrachial Tube | Challenge route |
| Exhl gas | Exhaled gas (breath) | System |
| Fcn | Function | Property |
| FFst | Fluid fast | Challenge |
| FIGO | International Federation of Gynecology and Obstetrics | Method |
| Find | Finding | Property |
| FINDRISC | Finnish Diabetes Risk Score | Method |
| FL | Femur length | Method |
| FldConduct | Fluid Conductance | Property |
| FldResist | Fluid Resistance | Property |
| Floc | Flocculation Assay | Method |
| FNA | Fine needle aspiration | System |
| Freq | Frequency | Property |
| frst | First value observed during an interval | Timing |
| Gast fld | Gastric fluid/contents | System |
| GC-MS | Gas chromatography-mass spectrometry | Method |
| GE | Greater than or equal to | Component; Timing |
| Genital fld | Genital fluid | System |
| Genital loc | Genital lochia | System |
| Genital muc | Genital mucus | System |
| Geno | Genotype | Property |
| GT | Greater than | Timing |
| Gt 1H | Greater than 1 hour | Timing |
| GTT | Gastronomy Tube | Challenge route |
| GU | GU Irrigant | Challenge route |
| HA | Hemagglutination | Method |
| HAI | Hemagglutination Inhibition | Method |
| HC | Head circumference | Method |
| Head>Cerebral vessels | Head>Cerebral vessels | System |
| HIV | Human immunodeficiency virus | Component |
| HLA | Human leukocyte antigen | Component (also Class) |
| HNA | Human neutrophil alloantigen | Component (also Class) |
| HOOS-PS | Hip disability and Osteoarthritis Outcome Score – Physical Function Shortform | Method |
| HPA | Human platelet antigen | Component (also Class) |
| HSVS | Housing Stability Vital Signs | Method |
| HTLV 1 | human t-cell lymphotropic virus-1 | Component |
| Hx | History | Property |
| IA | Immunoassay | Method |
| IA.MTTT | Immunoassay Modified two-tiered testing | Method |
| IA | Intra-arterial | Challenge route |
| IADL | Instrumental activities of daily living | Component |
| IB | Immune Blot | Method |
| IB | Intrabursal | Challenge route |
| IC | Intracardiac | Challenge route |
| ICD | International classification of diseases | Component |
| ICN | Intracervical (uterus) | Challenge route |
| ICP | Inductively Coupled Plasma | Method |
| ID | Identifier | Property |
| ID | Intradermal | Challenge route |
| IF | Immune Fluorescence | Method |
| Ig | immunoglobulin | Component |
| IgA | immunoglobulin A | Component |
| IgD | immunoglobulin D | Component |
| IgE | immunoglobulin E | Component |
| IgG | immunoglobulin G | Component |
| IgM | immunoglobulin M | Component |
| IgV | immunoglobulin V | Component |
| IH | Inhalation | Challenge route |
| IHA | Intrahepatic Artery | Challenge route |
| IM | Intramuscular | Challenge route |
| Imp | Impression/interpretation of study | Property |
| IN | Intranasal | Challenge route |
| Inhl gas | Inhaled gas | System |
| Instrct | Instructions | Property |
| Inverse VI | Inverse Inspired Volume | Property |
| InvLen | Inverse Length | Property |
| IO | Intraocular | Challenge route |
| IP | Intraperitoneal | Challenge route |
| IS | Intrasynovial | Challenge route |
| IT | Intrathecal | Challenge route |
| IU | Intrauterine | Challenge route |
| IV | Intravenous | Challenge route |
| KOOS-PS | Knee injury and Osteoarthritis Outcome Score – Physical Function Shortform | Method |
| LA | Latex Agglutination | Method |
| LaCnc | Log Arbitrary Concentration | Property |
| Len | Length | Property |
| LenFr | Length Fraction | Property |
| LenRto | Length Ratio | Property |
| LHR | Leukocyte Histamine Release | Method |
| LKSS | Lysholm Knee Scoring Scale | Method |
| LnCnc | Log Number Concentration | Property |
| LnRto | Log Number Ratio | Property |
| Loc | Location | Property |
| LogInvPct | Log Inverse Percent | Property |
| LogLenRto | Log Length Ratio | Property |
| LogRtoElp | Log Ratio Electrical Potential | Property |
| Lower extremity.left>Foot subtalar joint | Lower extremity.left>Foot subtalar joint | System |
| Lower extremity.left>Thigh.soft tissue | Lower extremity.left>Thigh.soft tissue | System |
| LRat | Length Rate | Property |
| LsCnc | Log Substance Concentration | Property |
| Lt 1H | Less than 1 hour | Timing |
| Lung tiss | Lung tissue | System |
| max | Maximum value over interval | Timing |
| MCnc | Mass Concentration | Property |
| MCncDiff | Difference in Mass Concentration | Property |
| MCncSq | Mass Concentration Squared | Property |
| MCnt | Mass Content | Property |
| MCPctDiff | Percent Difference in Mass Concentration | Property |
| MDiff | Mass Difference | Property |
| mean | Mean of all of the values observed on the interval (This is the default selection.) | Timing |
| Me-PFOSA-AcOH | 2-N-Methyl-perfluorooctanesulfonamide acetate | Component |
| MFr | Mass Fraction | Property |
| MFr.DF | Mass Decimal Fraction | Property |
| MFrDiff | Mass Fraction Difference | Property |
| MIC | Minimum Inhibitory Concentration | Method |
| MIC.VOC | Minimum Inhibitory Concentration Volatile Organic Compounds | Method |
| min | Minimum value over interval | Timing |
| MLC | Minimum Lethal Concentration | Method |
| MM | Mucus Membrane | Challenge route |
| Molgen | Molecular Genetics | Method |
| MoM | Multiple of the Median | Property |
| Morph | Morphology | Property |
| MPSS | Mainz Pain Staging System | Method |
| MR | Magnetic resonance | Method |
| MRat | Mass Rate | Property |
| MRatRange | Mass Rate Range | Property |
| MRC | Medical Research Council | Method |
| MRto | Mass Ratio | Property |
| MSCnc | Mass or Substance Concentration | Property |
| MTH | Mouth/Throat | Challenge route |
| Multi | “Multi” | Scale |
| Nar | Narrative | Scale |
| Naric | Number Aeric (number per area) | Property |
| NCHC | Norwalk Community Health Center Screening Tool | Method |
| NCnc | Number Concentration (count/vol) | Property |
| NCncRange | Number Concentration (count/vol) Range | Property |
| NCnt | Number Content = Count/Mass | Property |
| Neut | Virus Neutralization | Method |
| NFr | Number Fraction | Property |
| NFr.DF | Decimal number fraction | Property |
| NG | Nasogastric | Challenge route |
| NIPS | Neonatal Infant Pain Scale | Method (also Class) |
| Nom | Nominal | Scale |
| NOS | not otherwise specified | Component |
| NP | Nasal Prongs | Challenge route |
| Nph | Naspopharynx | System |
| NPP | Non-physician practitioner | Part description |
| NRat | Number=Count/Time | Property |
| NRS | Nutritional Risk Screening | Method |
| NRto | Number Ratio | Property |
| NS | Nasal | Challenge route |
| NT | Nasotrachial Tube | Challenge route |
| Num | Number | Property |
| NumDiff | Number Difference | Property |
| NumRange | Number Range | Property |
| OD | Optical Density | Property |
| ODI | Oswestry Disability Index | Method |
| OES | Optical Emission Spectrometry | Method |
| OP | Ophthalmic | Challenge route |
| Ord | Ordinal | Scale |
| OrdQn | Quantitative or Ordinal | Scale |
| Osmol | Osmolality | Property |
| OT | Otic | Challenge route |
| OTH | Other/Miscellaneous | Challenge route |
| PCFS | Post Covid-19 Functional Status | Method |
| PctDiff | Percent Difference | Property |
| Pericard fld | Pericardial fluid | System |
| Periton fld | Peritoneal fluid /ascites | System |
| PF | Perfusion | Challenge route |
| PFOS | perfluorooctane sulfonic acid | Component |
| Placent | Placenta | System |
| Plas | Plasma | System |
| Plr fld | Pleural fluid (thoracentesis fld) | System |
| Pn | Person Name | Property |
| PNDS | Perioperative Nursing Data Set | Method |
| PO | Oral | Challenge route |
| PPP | Platelet poor plasma | System |
| PPres | Pressure (partial) | Property |
| PPresDiff | Difference in Partial Pressure | Property |
| PPresRto | Partial Pressure Ratio | Property |
| PR | Rectal | Challenge route |
| Prctl | Percentile | Property |
| Pres | Pressure | Property |
| PresRat | Pressure Rate | Property |
| PresRto | Pressure Ratio | Property |
| PressDiff | Difference | Property |
| Prid | Presence or Identity | Property |
| Procedure dur | Duration of the procedure (surgery, etc.) | Timing |
| PROWL | Patient-reported outcomes with LASIK | Method |
| PRP | Platelet rich plasma | System |
| PrThr | Presence or Threshold | Property |
| Pt | To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | Timing |
| PT+CT perf | PT+CT.perfusion | Method |
| pVNT | Pseudovirus Neutralization | Method |
| Qn | Quantitative | Scale |
| RAST | Radioallergosorbent test | Method |
| RatDiff | Rate Difference | Property |
| RBC | Erythrocytes | System |
| RBCCo | Red Blood Cells Cord | System |
| RelACnc | Relative Arbitrary Concentration | Property |
| RelCCnc | Relative Catalytic Concentration | Property |
| RelEngRat | Relative Power | Property |
| RelFldConduct | Relative Fluid Conductance | Property |
| RelFldResist | Relative Fluid Resistance | Property |
| RelInvVI | Relative Inverse Volume Inspired | Property |
| RelMCnc | Relative Mass Concentration | Property |
| RelMRat | Relative Mass Rate | Property |
| RelRto | Relative Ratio | Property |
| RelSCnc | Relative Substance Concentration | Property |
| RelSoundInt | Relative Sound Intensity | Property |
| RelSRat | Relative Substance Rate | Property |
| RelTime | Relative Time | Property |
| RelVol | Relative Volume | Property |
| RelVRat | Relative Volume Rate | Property |
| Resis | Resistance | Property |
| Resp.lower | Lower respiratory | System |
| REVEAL | Registry to Evaluate Early and Long-Term PAH Disease Management | Method |
| RF | Radiofluoroscopy | Method |
| RFLP | Restriction Fragment Length Polymorphism | Method |
| RFLP.rRNA | Restriction Fragment Length Polymorphism on rRNA | Method |
| RIA | Radioimmunoassay | Method |
| RM | Rebreather Mask | Challenge route |
| RMDQ | Roland Morris Disability Questionnaire | Method |
| RNA | ribonucleic acid | Component |
| RPR | Rapid Plasma Reagin | Method |
| RptPeriod | Reporting period | Timing |
| rRNA | ribosomal ribonucleic acid | Component |
| RT-QuIC | Real-time quaking-induced conversion | Method |
| RUDAS | Rowland Universal Dementia Assessment Scale | Method |
| SatFr | Saturation Fraction | Property |
| SBT | Serum Bacterial Titer | Method |
| SC | Subcutaneous | Challenge route |
| SCnc | Substance Concentration | Property |
| SCncDiff | Difference in Substance Concentration | Property |
| SCncSq | Substance Concentration Squared | Property |
| SCnt | Substance Content | Property |
| ScoreDiff | Score Difference | Property |
| ScoreRange | Score range | Property |
| SD | Soaked Dressing | Challenge route |
| SDOM | Standard Dermatology Outcome Measures | Method |
| SemiQn | Semiquantitative | Scale |
| Seq | Nucleotide Sequence | Property |
| Ser | Serum | System |
| SFr | Substance Fraction | Property |
| SFr.DF | Decimal Substance Fraction | Property |
| SL | Sublingual | Challenge route |
| SOFA | Sequential Organ Failure Assessment | Method |
| SPR | Surface plasmon resonance | Method |
| Sptt | Sputum – tracheal aspirate | System |
| SRat | Substance Rate | Property |
| SRto | Substance Ratio | Property |
| Stdy | Duration of the study | Timing |
| Sub | Substance Amount | Property |
| SPR | Surface Plasmon Resonance | Method |
| Susc | Susceptibility | Property |
| Synv fld | Synovial fluid (Joint fluid) | System |
| TAPS | Tobacco, Alcohol, Prescription medications, and other Substance use assessment | Method |
| TD | Transdermal | Challenge route |
| Tele | Telephone Number | Property |
| Temp | Temperature | Property |
| TempDiff | Temperature Difference | Property |
| ThrACnc | Threshold Arbitrary Concentration | Property |
| ThreshNum | Threshold Number | Property |
| ThrMCnc | Threshold Mass Concentration | Property |
| ThrSCnc | Threshold Substance Concentration | Property |
| Thrt | Throat | System |
| Tigi | Tissue large intestine | System |
| TimeDif | Difference in Time Duration | Property |
| TimeFr | Time Fraction | Property |
| Tiss | Tissue, unspecified | System |
| TissCo | Cord Tissue | System |
| Titr | Dilution Factor (Titer) | Property |
| TL | Translingual | Challenge route |
| TmElpot | Time Electrical Potential | Property |
| TmMCnc | Time mass concentration | Property |
| TmSCnc | Time substance concentration | Property |
| TmStp | Time Stamp—Date and Time | Property |
| TmStpRange | Time Stamp Range | Property |
| TP | Topical | Challenge route |
| TQ2 | Timing Quantity 2 | Property |
| TRA | Tracheostomy | Challenge route |
| TRH | Thyrotropin-releasing hormone | Challenge route |
| TRto | Time Ratio | Property |
| Tscore | T Score | Property |
| TscoreDiff | T Score Difference | Property |
| Tsmi | Tissue small intestine | System |
| Txt | Text | Property |
| Ulc | Ulcer | System |
| Unk sub | Unknown substance | System |
| UR | Urethral | Challenge route |
| Urethra | Urethra | System |
| URI | Uniform Resource Identifier | Property |
| Urine sed | Urine sediment | System |
| US | Ultrasound | Method |
| Vag | Vagina | System |
| VAP | Vertical Auto Profile | Method |
| VC | Visual Count | Method |
| VCF | Variant Call File | Property |
| VCnt | Volume Content | Property |
| VDRL | Venereal Disease Research Laboratory | Method |
| Vel | Velocity | Property |
| VelRat | Velocity Rate | Property |
| VelRto | Velocity Ratio | Property |
| VFr | Volume Fraction | Property |
| VFr.DF | Volume Decimal Fraction | Property |
| VFrDiff | Difference in Volume Fraction | Property |
| VG | Vaginal | Challenge route |
| Visc | Viscosity | Property |
| Vitr fld | Vitreous Fluid | System |
| VM | Ventimask | Challenge route |
| Vol | Volume | Property |
| VPctDiff | Percent Volume Difference | Property |
| VRat | Volume Rate | Property |
| VRatCnt | Volume Rate Content | Property |
| VRatRto | Volume Rate Ratio | Property |
| VRto | Volume Ratio | Property |
| VRtoPctDiff | Percent Volume Ratio Difference | Property |
| WBC | Leukocytes | System |
| WHOQOL_BREF | WHO Quality of life-BREF | Method |
| WND | Wound | Challenge route |
| Xad | Extended Address | Property |
| XR.3D | X-ray 3 dimensional | Method |
| XXX | Not specified | Timing; System |
| XXX^min | Unspecified time minimum | Timing |
| Zscore | Zscore | Property |
| RTS | Revised Trauma Score | Method |
| Mut Anl | Molgen.targeted mutational analysis | Method |